There is significant potential in decentralized models and digital health technology to expand diversity in clinical trials.
Monica Chmielewski and Alexandra Maulden
Advertisement
Articles by Monica Chmielewski and Alexandra Maulden
Advertisement
Latest Updated Articles
An Overview of FDA Diversity-Related Documents for Clinical TrialsPublished: May 30th 2024 | Updated:
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
